A multicenter, investigative study of the safety and efficacy of extended administration of aripiprazole in combination with mood stabilizer [lithium, valproic acid] for the treatment of patients with bipolar disorder experiencing a manic or mixed episode.

Trial Profile

A multicenter, investigative study of the safety and efficacy of extended administration of aripiprazole in combination with mood stabilizer [lithium, valproic acid] for the treatment of patients with bipolar disorder experiencing a manic or mixed episode.

Completed
Phase of Trial: Phase III

Latest Information Update: 19 May 2016

At a glance

  • Drugs Aripiprazole (Primary)
  • Indications Bipolar I disorders
  • Focus Therapeutic Use
  • Sponsors Otsuka Pharmaceutical
  • Most Recent Events

    • 11 Jul 2011 Actual end date (Mar 2007) added as reported by ClinicalTrials.gov.
    • 11 Jul 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 05 Mar 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top